<!DOCTYPE html>
<html lang="es" dir="ltr" prefix="content: http://purl.org/rss/1.0/modules/content/  dc: http://purl.org/dc/terms/  foaf: http://xmlns.com/foaf/0.1/  og: http://ogp.me/ns#  rdfs: http://www.w3.org/2000/01/rdf-schema#  schema: http://schema.org/  sioc: http://rdfs.org/sioc/ns#  sioct: http://rdfs.org/sioc/types#  skos: http://www.w3.org/2004/02/skos/core#  xsd: http://www.w3.org/2001/XMLSchema# ">
  <head>
    <meta charset="utf-8" />
<link rel="canonical" href="7677.html" />
<meta name="news_keywords" content="Nicaragua" />
<meta name="rights" content="Creative Commons" />
<meta name="description" content="Gloria Guillo, October 8th 2025" />
<meta name="Generator" content="Drupal 9 (https://www.drupal.org)" />
<meta name="MobileOptimized" content="width" />
<meta name="HandheldFriendly" content="true" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<link rel="icon" href="../sites/default/files/tortilla.png" type="image/png" />

    <title>Nicaragua&#039;s public health priorities versus US pharmaceuticals extortion | Tortilla con Sal</title>
    <link rel="stylesheet" media="all" href="../sites/default/files/css/css_3SyR5VbMXs53wTionKi_mw7U_JUmZQhBDN61ZU74rcw.css" />
<link rel="stylesheet" media="all" href="../sites/default/files/css/css_I7G8mQvgcvpjAQ5UbqaJ1nhUnVt5gzEgJZ5yUsX5p7w.css" />
<link rel="stylesheet" media="print" href="../sites/default/files/css/css_Z5jMg7P_bjcW9iUzujI7oaechMyxQTUqZhHJ_aYSq04.css" />

    
  </head>
  <body class="layout-one-sidebar layout-sidebar-second path-node page-node-type-article">
        <a href="7677.html#main-content" class="visually-hidden focusable skip-link">
      Pasar al contenido principal
    </a>
    
      <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas>
    <div id="page-wrapper">
  <div id="page">
    <header id="header" class="header" role="banner">
      <div class="section layout-container clearfix">
        
          <div class="clearfix region region-header">
    <div id="block-bartik-branding" class="clearfix site-branding block block-system block-system-branding-block">
  
    
        <a href="../index.html" rel="home" class="site-branding__logo">
      <img src="../sites/default/files/proceres_ancho_700px.png" alt="Inicio" />
    </a>
        <div class="site-branding__text">
              <div class="site-branding__name">
          <a href="../index.html" rel="home">Tortilla con Sal</a>
        </div>
                    <div class="site-branding__slogan">Un enfoque diferente - Nicaragua - A different focus</div>
          </div>
  </div>

  </div>

          <div class="region region-primary-menu">
    
<nav role="navigation" aria-labelledby="block-bartik-main-menu-menu" id="block-bartik-main-menu" class="block block-menu navigation menu--main">
            
  <h2 class="visually-hidden" id="block-bartik-main-menu-menu">Navegación principal</h2>
  

        <div class="content">
            <div class="menu-toggle-target menu-toggle-target-show" id="show-block-bartik-main-menu"></div>
      <div class="menu-toggle-target" id="hide-block-bartik-main-menu"></div>
      <a class="menu-toggle" href="7677.html#show-block-bartik-main-menu">Mostrar &mdash; Navegación principal</a>
      <a class="menu-toggle menu-toggle--hide" href="7677.html#hide-block-bartik-main-menu">Ocultar &mdash; Navegación principal</a>
      
              <ul class="clearfix menu">
                    <li class="menu-item">
        <a href="../../archivos.html" title="Tortilla con Sal Archivo / Archive ">Archivo / Archive</a>
              </li>
                <li class="menu-item">
        <a href="../search.html" data-drupal-link-system-path="search">Buscar</a>
              </li>
                <li class="menu-item">
        <a href="../activity.html" data-drupal-link-system-path="activity">Contenido reciente</a>
              </li>
        </ul>
  


    </div>
  </nav>

  </div>

      </div>
    </header>
          <div class="highlighted">
        <aside class="layout-container section clearfix" role="complementary">
            <div class="region region-highlighted">
    <div data-drupal-messages-fallback class="hidden"></div>

  </div>

        </aside>
      </div>
            <div id="main-wrapper" class="layout-main-wrapper layout-container clearfix">
      <div id="main" class="layout-main clearfix">
        
        <main id="content" class="column main-content" role="main">
          <section class="section">
            <a id="main-content" tabindex="-1"></a>
              <div class="region region-content">
    <div id="block-bartik-page-title" class="block block-core block-page-title-block">
  
    
      <div class="content">
      

  <h1 class="title page-title"><span property="schema:name" class="field field--name-title field--type-string field--label-hidden">Nicaragua&#039;s public health priorities versus US pharmaceuticals extortion</span>
</h1>


    </div>
  </div>
<div id="block-bartik-content" class="block block-system block-system-main-block">
  
    
      <div class="content">
      
<article data-history-node-id="7677" role="article" about="/bitacora/node/7677" typeof="schema:Article" class="node node--type-article node--promoted node--view-mode-full clearfix">
  <header>
    
            <span property="schema:name" content="Nicaragua&#039;s public health priorities versus US pharmaceuticals extortion" class="rdf-meta hidden"></span>

          <div class="node__meta">
        <article typeof="schema:Person" about="/bitacora/user/1" class="profile">
  </article>

        <span>
          Enviado por <span rel="schema:author" class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/bitacora/user/1" typeof="schema:Person" property="schema:name" datatype="">tortilla</span></span>
 el <span property="schema:dateCreated" content="2025-10-08T15:05:03+00:00" class="field field--name-created field--type-created field--label-hidden">Mié, 08/10/2025 - 09:05</span>
        </span>
          <span property="schema:dateCreated" content="2025-10-08T15:05:03+00:00" class="rdf-meta hidden"></span>

      </div>
      </header>
  <div class="node__content clearfix">
    
            <div property="schema:text" class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p><em>Gloria Guillo, October 8th 2025</em></p>

<div class="text-align-center" style="float: right; margin: 10px;" width="420"><img alt="" height="500" src="https://drogueriayfarmacialapaz.com/wp-content/uploads/2023/05/Albendazol-1.jpg" width="400" /><br />
<em>En EE.UU. 400mg de Albendazol cuesta cientos de dólares </em></div>

<p>In <a href="https://www.vanityfair.com/hollywood/2017/06/the-graduate-50th-anniversary">The Graduate</a> (1967), a family friend corners young Benjamin Braddock with one word of advice for his future: “Plastics.” It was a nod to a booming, transformative industry—lucrative, ubiquitous, and shaping modern life. Today, a new contender emerges in the pharmaceutical realm: anti-parasitical drugs like <a href="https://www.npr.org/sections/goatsandsoda/2017/12/11/567753423/why-a-pill-thats-4-cents-in-tanzania-costs-up-to-400-in-the-u-s">albendazole</a>. These medications, critical for treating parasitic infections, are gaining prominence not only for their traditional uses but also for novel applications against viruses and cancer, positioning them as a medical “plastic” of our era—valuable, versatile, yet mired in controversy due to stark pricing disparities. In the U.S., a single 400 mg dose of albendazole can cost over $380, while in <a href="https://www.npr.org/sections/goatsandsoda/2017/12/11/567753423/why-a-pill-thats-4-cents-in-tanzania-costs-up-to-400-in-the-u-s">Nicaragua</a>, the same dose is mere pennies. This contrast reveals a U.S. system driven by profit over public health, exacerbated by emerging dietary trends like <a href="https://www.grandviewresearch.com/industry-analysis/edible-insects-market">insect-based foods</a> that heighten parasite risks. This article explores albendazole’s rising importance, contrasts its pricing between the U.S. and Nicaragua, and critiques how market dynamics exploit a drug poised to redefine medicine.</p>

<p>Al<strong>bendazole’s Rising Value: The New “Plastic”</strong></p>

<p>Albendazole, a broad-spectrum antiparasitic, treats infections like hookworm, pinworm, ascariasis, neurocysticercosis, and hydatid disease. Included on the <a href="https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02">World Health Organization’s List of Essential Medicines</a>, it’s a cornerstone for global health, especially in tropical regions where parasitic diseases are endemic. Its value is soaring due to emerging applications beyond parasites. Recent <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8255490/">studies</a> show albendazole inhibits viral replication in diseases like hepatitis C and dengue, with clinical trials exploring its potential against HIV. In oncology, it disrupts microtubule formation in <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5641066/">cancer cells</a>, showing promise in colorectal and lung cancer models, with phase II trials underway. These uses elevate albendazole’s status, making it a versatile asset akin to plastics in The Graduate—a game-changer with vast potential.</p>

<p>Yet, this potential is overshadowed by a darker trend: the push for <a href="https://www.grandviewresearch.com/industry-analysis/edible-insects-market">insect-based foods</a>. Promoted as sustainable protein sources, insects like crickets and mealworms are gaining traction, with the global edible insect market projected to reach $7.96 billion by 2030. Initiatives like the <a href="https://food.ec.europa.eu/food-safety/novel-food/authorisations/approval-insect-novel-food_en">EU’s Novel Foods Regulation</a> and U.S. startups advocate for insect consumption to combat climate change. However, insects can harbor <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6613697/">parasites</a> like tapeworms and protozoa, transmissible to humans if improperly processed. A 2023 <a href="https://www.sciencedirect.com/science/article/pii/S0956713523001234">study</a> found that 30% of farmed crickets carried parasitic larvae, raising risks as consumption scales. This trend amplifies the need for drugs like albendazole, yet access is starkly unequal.</p>

<p><strong>U.S. Pricing: A Profit-Driven Crisis</strong></p>

<p>In the U.S., albendazole’s retail price for a standard course (two 200 mg tablets) can exceed $700 without insurance, though discounts via <a href="https://www.goodrx.com/albendazole">GoodRx</a> or SingleCare drop it to $24–$33. This is astronomical compared to <a href="https://www.npr.org/sections/goatsandsoda/2017/12/11/567753423/why-a-pill-thats-4-cents-in-tanzania-costs-up-to-400-in-the-u-s">Nicaragua</a>, where a 400 mg dose costs about $0.04–$0.10, reflecting subsidized generics and government price controls. The U.S. price surge, despite albendazole being off-patent since the 1990s, stems from market dynamics rather than production costs, which are minimal globally (<a href="https://www.healthaffairs.org/doi/10.1377/hlthaff.2019.01487">Health Affairs</a>).</p>

<p>In 2010, GlaxoSmithKline sold U.S. rights to CorePharma, then Amedra Pharmaceuticals (private equity-backed), and finally Impax Laboratories (now Amneal). This created a near-monopoly, with Impax as the sole supplier. A manufacturing pause triggered <a href="https://www.fda.gov/drugs/drug-shortages/drug-shortages-list">FDA shortages</a>, blocking generic competitors due to bioequivalence rules. Prices soared from $6 per dose in 2010 to $190+ per tablet today—an 8,000% hike (<a href="https://khn.org/news/price-hikes-on-old-drugs-like-albendazole-put-squeeze-on-hospitals/">Kaiser Health News</a>). Low U.S. demand (e.g., <a href="https://www.cdc.gov/parasites/pinworm/index.html">pinworms</a> affect ~10% of children yearly; hookworm cases are rare but rising) discourages new manufacturers, as market entry costs outweigh profits. Unlike Nicaragua’s state-driven model, the U.S.’s fragmented system—where insurers must cover FDA-approved drugs—enables “rent-seeking,” with companies exploiting niche markets (<a href="https://www.brookings.edu/research/the-high-cost-of-prescription-drugs-in-the-united-states/">Brookings</a>).</p>

<p>This mirrors broader trends: mebendazole (another antiparasitic) jumped 8,000% to $430/dose, and praziquantel rose 500% (<a href="https://www.kff.org/health-costs/issue-brief/trends-in-prescription-drug-pricing/">KFF</a>). Private equity’s role prioritizes short-term gains, and <a href="https://www.statnews.com/2021/03/24/generic-drug-price-hikes/">FDA barriers</a> during shortages stifle competition. For clinics serving immigrants or refugees, where parasitic infections are more common, 15% now skip screening asymptomatic patients due to costs, risking incomplete treatment (<a href="https://www.nejm.org/doi/full/10.1056/NEJMp1908049">New England Journal of Medicine</a>).</p>

<p><strong>Nicaragua: Pennies for Health Equity</strong></p>

<p>In contrast, <a href="https://www.npr.org/sections/goatsandsoda/2017/12/11/567753423/why-a-pill-thats-4-cents-in-tanzania-costs-up-to-400-in-the-u-s">Nicaragua’s</a> albendazole pricing—$0.04–$0.10 per 400 mg dose—reflects a health system prioritizing access over profit. The Sandinista government, since 2007, has expanded public healthcare, subsidizing generics through partnerships with Latin American manufacturers like Cuba’s <a href="https://www.reuters.com/article/us-nicaragua-healthcare/nicaragua-boosts-healthcare-access-in-rural-areas-idUSKBN1ZG1Y5">Labiofam</a>. Programs like the <a href="https://www.paho.org/en/topics/neglected-infectious-diseases">WHO’s mass drug administration</a> for soil-transmitted helminths ensure free or low-cost albendazole for rural communities, where 60% of Nicaraguans face parasitic risks. Price controls and bulk procurement keep costs down, unlike the U.S.’s market-driven model. Nicaragua’s approach, rooted in socialized medicine, delivers albendazole at a fraction of U.S. prices, even as its GDP per capita ($2,255 in 2024) is dwarfed by the U.S.’s ($81,000) (<a href="https://www.worldbank.org/en/country/nicaragua/overview">World Bank</a>).</p>

<p>This disparity highlights systemic priorities. Nicaragua’s model, while not perfect—rural access gaps persist—ensures affordability, aligning with global health equity goals. The U.S., by contrast, allows unchecked price hikes, with insurers and patients bearing the cost. For a drug now critical against viruses and cancer, and increasingly vital as insect-based diets raise parasite risks, this inequity is stark.</p>

<p><strong>Insect Foods and Parasite Risks</strong></p>

<p>The global push for <a href="https://www.fao.org/edible-insects/en/">insect consumption</a> amplifies albendazole’s importance. The UN’s Food and Agriculture Organization promotes insects as sustainable, with North American startups like Aspire Food Group scaling cricket farming. Yet, insects carry <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6613697/">parasites</a>—tapeworms, flukes, and protozoa—transmissible if undercooked or poorly sourced. A 2024 <a href="https://www.frontiersin.org/articles/10.3389/fmicb.2024.1344123/full">study</a> found 28% of market-sold mealworms harbored parasitic larvae, and improper farming hygiene increases risks. As insect foods enter mainstream diets (e.g., cricket flour in U.S. protein bars), demand for antiparasitics like albendazole could surge, especially in the U.S., where screening and treatment costs are prohibitive.</p>

<p><strong>The Broader Implications: Profit vs. People</strong></p>

<p>Albendazole’s U.S. pricing reflects a system where profit trumps need, unlike Nicaragua’s equitable model. The drug’s new roles—against viruses, cancer, and emerging parasite risks from insect diets—make it the “plastic” of modern medicine: transformative, indispensable, yet hoarded by market forces. In The Graduate, plastics symbolized opportunity; today, albendazole’s inaccessibility symbolizes greed. Its 8,000% price hike mirrors hikes in generics like <a href="https://www.rand.org/pubs/research_briefs/RB10023.html">insulin</a> (up 1,200% since 2002). The U.S. military health system, facing similar anthelmintic cost spikes, shifted to over-the-counter <a href="https://www.military.com/daily-news/2023/04/12/va-drug-price-hikes.html">pyrantel pamoate</a> ($15–$20) for pinworms.</p>

<p>Solutions exist: nonprofit generics like <a href="https://civicarx.org/about/">Civica Rx</a>, FDA reforms for faster approvals, or importing low-cost albendazole from countries like Nicaragua. Patient assistance programs or coupons help, but gaps remain for the uninsured. For now, patients can use <a href="https://www.goodrx.com/albendazole">GoodRx</a> to save up to 97% or explore alternatives like pyrantel, though less effective for complex infections. Nicaragua’s model—pennies for a dose—shows what’s possible when health trumps profit.</p>

<p><strong>Conclusion: A Call for Equity</strong></p>

<p>Albendazole, the new “plastic,” is poised to reshape medicine with its antiviral and anticancer potential, yet its U.S. price—$700 versus Nicaragua’s pennies—exposes a system prioritizing wealth over lives. As <a href="https://www.fao.org/edible-insects/en/">insect-based foods</a> raise parasite risks, affordable access becomes critical. Nicaragua’s approach, rooted in public health, contrasts sharply with U.S. market failures. Like Benjamin Braddock rejecting plastics’ hollow promise, we must demand a system where life-saving drugs aren’t luxuries. Equity, not exploitation, must define this new era.</p>

<p><strong><em><b><i>(*)</i></b></em></strong><em><i> Gloria Guillo is an investigative reporter working  for outlets like CovertAction Magazine and other on line news media outlets. She has also covered elections in Nicaragua, Venezuela and Brazil  and she has written extensively on the use of illegal unilateral coercive measures around the world in su.pport of the "Sanctions Kill" campaign</i></em></p>
</div>
        <div class="node__links">
    <ul class="links inline"><li class="comment-forbidden"></li></ul>  </div>

  </div>
</article>

    </div>
  </div>

  </div>

          </section>
        </main>
                          <div id="sidebar-second" class="column sidebar">
            <aside class="section" role="complementary">
                <div class="region region-sidebar-second">
    <div id="block-linksenlaces" class="block block-block-content block-block-content735bbc95-9dc3-4736-936a-ef54339c5d09">
  
      <h2>Links / Enlaces</h2>
    
      <div class="content">
      
            <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><div class="text-align-center">
<h3><em><a href="../../index.html">Home - Índice</a></em><br />
<a href="../../index.html"><img alt="map" height="120" src="../../images/nica_map_flag.png" width="120" /></a></h3>
</div>

<div class="text-align-center"><br />
<br />
<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="192" src="https://www.youtube.com/embed/9cagLi2LYq4" width="256"></iframe><br />
<strong>Concierto 46/19 Avanzando en la Revolución</strong></div>

<div class="text-align-center"><br />
<br />
<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="192" src="https://www.youtube.com/embed/WRDLXT4w5aQ" width="256"></iframe><br />
<strong>Erika Seyjas - Viva la Revolución</strong></div>

<div class="text-align-center"><br />
<br />
<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="192" src="https://www.youtube.com/embed/hu2qcAVZmNU" width="256"></iframe><br />
<strong>Nicaragua Fascinante e Irresistible</strong></div>

<div class="text-align-center"><br />
<br />
<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="192" src="https://rumble.com/embed/v2lf7sk/?pub=juws3" width="256"><br />
Liberarte en concierto en Rusia</iframe></div>

<p class="text-align-center"><em><strong>Liberarte en Concierto en Rusia</strong></em></p>

<p class="text-align-center"><em><strong><a href="2665.html"> <br />
Recursos Útiles para Referencia</a></strong></em></p>

<p> </p>

<p class="text-align-center"><br />
<strong><em><a href="../../archivos.html"><em>Tortilla con Sal Archivo</em></a></em></strong></p>
</div>
      
    </div>
  </div>

  </div>

            </aside>
          </div>
              </div>
    </div>
        <footer class="site-footer">
      <div class="layout-container">
                      </div>
    </footer>
  </div>
</div>

  </div>

    
    
  </body>
</html>
